摘要:
Objective: To explore the target and molecular mechanism of Cangfu Daotan pill in the treatment of polycystic ovary syndrome (PCOS) by network pharmacology. Methods: The main active components and corresponding targets of Cangfu Daotan pills were searched in the database of traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP). GeneCards database and OMIM database were used to search for disease targets of PCOS; the intersection of the target of Cangfu Daotan pill and the disease target of PCOS was drawn by using R to obtain the intersection gene; protein interaction network was constructed through String online database; Cytoscape (3.2.1) was used to construct a 'major component-disease-target' network diagram and analyze the important nodes therein; KEGG and GO enrichment analyses were carried out on the obtained intersection genes through org data packets in R. Results: Network pharmacology analysis showed that 151 active ingredients involved in pathways were screened out, 140 of which acted on PCOS, and 105 potential targets were used to exert therapeutic effects. After enrichment, 1900 GO biological signals and 143 KEGG signals were obtained, and the first 14 drug targets were screened out. Conclusion: Cangfu Daotan pill may mediate gene transcription regulation, lipid metabolism, inflammatory micro environment, insulin resistance, sex hormone axis, arteriosclerosis, interleukin immune regulation and other signals through regulating key targets of JUN, MAPK3, HSP90AA1, MAPK1, ESR1, NR3C1, APP, MAPK14, MAPK8, VEGFA, EGFR, RB1, AR, IL6, mediate gene transcription regulation, lipid metabolism, inflammatory micro environment, insulin resistance, sex hormone axis, arteriosclerosis, interleukin immune regulation, etc., and regulate biological processes such as drug reaction, nutrition and lipid metabolism, active oxygen, sugar metabolism, steroid hormone, etc. to achieve the effect of treating polycystic ovary syndrome.